Ahmed M

Johnson & Johnson, Titusville, NJ.

6 papers · 3 preprints · ORCID

ArticleKetamine

Comment on Esketamine 5 Years After Approval: Welcome New Data With Continuing Questions.

Ahmed M, Cabrera P, Doherty T +4

Europe PMC2026
PreprintKetamine

Ketamine persists within neuronal compartments long after systemic clearance

Cichon J, Bera K, Blumenfeld Z +16

Europe PMC2026
ArticlePsilocybin

Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia.

Askey T, Allen-Ross D, Luzyanin D +7

Europe PMC2026
ArticleKetamine

Efficacy and Safety of Ketamine or Esketamine versus Fentanyl-Class Opioids as Adjuncts to Propofol for Gastrointestinal Endoscopy: A Systematic Review and Meta-Analysis.

Inam K, Qazi MS, Ahmed M +7

Europe PMC2026
ArticleKetamine

"Efficacy and safety of esketamine for reducing sufentanil-induced cough: A meta-analysis of randomized controlled trials".

Hassan M, Hussain M, Khair-Un-Nisa +1

Europe PMC2025
PreprintPsilocybin

Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia

Askey T, Allen-Ross D, Luzyanin D +7

Europe PMC2025
ArticleKetamine

Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis Almost 5 Years After First Approval.

Sanacora G, Ahmed M, Brown B +11

Europe PMC2025
PreprintPsilocybin

Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates the gabapentin-mediated analgesia

Askey T, Allen-Ross D, Lasrado R +6

Europe PMC2024
ArticlePsilocybin

The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?

Mohamed A, Touheed S, Ahmed M +2

Europe PMC2022